Albert B Sabin Vaccine Institute Inc
Income Statement
Fiscal Year Start:
Jan 1
Data visualization unavailable
Revenues in 2024
$35,914,020
Program Services
N/A
Contributions
N/A
Investments
N/A
Government Grants
N/A
Fundraising Events
N/A
Membership Dues
N/A
Expenses in 2024
$39,878,340
Fees to Service Providers
61%
Salaries & Benefits
27%
Grants
6%
Other
4%
Offices, Occupancy & IT
2%
Depreciation
<1%
Advertising & Promotion
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$656,559
$118,433
-82%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$39,331,759
$36,134,625
-8%
Membership Dues
$20,355
$0
-100%
Investments
$98,622
$108,871
+10%
Other
$30,205
-$447,909
-1583%
Total Revenues
$40,137,500
$35,914,020
-11%
Expenses
2023
2024
Change
Grants
$3,064,520
$2,345,063
-23%
Benefits to Members
$0
$0
-
Salaries & Benefits
$9,595,310
$10,645,907
+11%
Fees to Service Providers
$24,882,869
$24,267,627
-2%
Advertising & Promotion
$45,431
$25,873
-43%
Offices, Occupancy & IT
$646,664
$722,876
+12%
Interest
$0
$0
-
Depreciation
$429,297
$316,119
-26%
Other
$3,502,674
$1,554,875
-56%
Total Expenses
$42,166,765
$39,878,340
-5%
Net income
2023
2024
Change
Net income
-$2,029,265
-$3,964,320
-95%
Functional Expenses
Summary
2023
2024
Change
Program
$37,285,537
$35,836,449
-4%
Admin
$4,603,000
$3,476,853
-24%
Fundraising
$278,228
$565,038
+103%
Total Expenses
$42,166,765
$39,878,340
-5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)